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pp6Ocsrc Is Expressed in Human Fetal and Adult Brain
JOHN P. SORGE, MD, LAURIE K. SORGE, PhD,
and PATRICIA F. MANESS, PhD
Human cells contain a tyrosine-specific protein kinase,
pp6Oc-src, that is highly homologous to the oncogene
product, pp60V-SrC, from Rous sarcoma virus but is of un-
known function. The expression ofhuman pp6O"csrc was
examined in tissues obtained from human adults and
fetuses of 20-32 weeks' gestational age. pp6O`csrc was
quantitated in tissue extracts by measurement of its pro-
tein kinase activity by the use of the immune complex
protein kinase assay. Brain showed the highest levels of
pp6OC.srC protein kinase activity, but all other human tis-
sues examined had significant levels. Fetal tissues, includ-
ing brain, showed three- to eight-fold higher levels of
pp6Oc-src kinase activity than the corresponding adult tis-
sues. pp6Oc-src kinase was found to be uniformly dis-
THE GENOME of animal cells contains cellular on-
cogenes homologous to the transforming genes of ani-
mal retroviruses (reviewed in Bishop and Varmus1). Al-
though the function of cellular oncogenes is obscure,
the conservation of their DNA sequences over a broad
evolutionary range2 suggests that they may code for in-
dispensable cellular functions. The known ability of vi-
ral oncogenes to perturb cellular differentiation and
proliferation in infected cells suggests that the cellular
oncogenes may play a role in normal growth or differen-
tiation.
The normal cellular oncogene c-src encodes and ex-
presses a tyrosine-specific protein kinase, pp6Oc-src, that
is homologous to the transforming protein of Rous sar-
coma virus. In the chick embryo, pp6Oc-src kinase ac-
tivity has been demonstrated in all tissues but was found
to be especially high in those of neural origin.34
pp6Oc-src expression in the neural retina increases sud-
denly during mid to late organogenesis and decreases
as hatching is approached, indicating a possible func-
tional role for pp6Oc-src in development of the ner-
vous system. Immunocytochemical localization of
pp6Oc-src in the developing chick retina established that
pp6Oc-src was the product of neurons, and that its ex-
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tributed in the adult brain; frontal, occipital, and parie-
tal cortex, and cerebellum expressed equivalent amounts
of pp60`csrc kinase activity. The protein kinase activity
in human tissues exhibited properties characteristic of
pp60`sc in other species, namely, tyrosine-specific phos-
phorylation ofspecific antibody heavy chains, autophos-
phorylation of a 60,000 Mr protein following immuno-
precipitation with a monoclonal antibody specific for
pp6OsrC, and sensitivity to inhibition by P',P4-di(ade-
nosine-5')tetraphosphate. The high levels of human
pp60`csre in fetal tissues, particularly in brain, suggest a
possible function in developmental processes. (Am J
Pathol 1985, 119:151-157)
pression was activated at the onset of neuronal differen-
tiation.5
Less is known about pp6Oc-src in human cells.
pp6Oc-src has been demonstrated in cultured human
fibroblasts and epidermoid carcinoma cells6-8 and in
some human sarcomas and mammary carcinomas,9 but
it has not been characterized developmentally. In this
study we examined the tissue distribution of pp6Oc-src
in human fetal and adult tissues. Fetal tissues were found
to contain significantly greater levels of pp6Oc-src than
corresponding adult tissues, with the highest levels of
pp6Oc-src present in fetal brain. The results presented
here support a role for pp6Oc-src in developmental
processes, particularly those that are important in ner-
vous tissues.
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Materials and Methods
Preparation of Extracts
Human tissues obtained at autopsy or following ther-
apeutic abortion (less than 20 weeks' gestation) were
frozen in liquid nitrogen and stored at - 70 C until use.
Tissues were homogenized in four volumes of lysis
buffer (25 mM potassium phosphate (pH 7.1), 1.25 mM
EDTA, 0.67o (wt/vol) sodium deoxycholate, 1.25%
(vol/vol) Nonidet P-40, 12.5 mM NaF, 125 kIU/ml
aprotinin, 2.5 mM dithiothreitol) at 4 C for 2 minutes
in a TekMar homogenizer (TekMar Co., Cincinnati,
Ohio) followed by 10 strokes of a Dounce tissue grinder
fitted with a loose pestle and 10 strokes with a tight
pestle. Homogenates were centrifuged at 100,000g for
1 hour, and the supernatants were retained. Pellets were
reextracted in the same manner, and the resulting su-
pernatants from both centrifugations were stored at
-70 C. The first supernatant contained 92% of the to-
tal extracted protein and 9307o of the total pp6Oc-src ki-
nase activity. Protein was determined by the Lowry
method. 10
Immune Complex Kinase Assays
Immune complex kinase assays for pp6Oc-src protein
kinase were carried out by a modification"1 of the
method described previously.12 pp6Oc-src was im-
munoprecipitated from embryo extracts with the use
of an excess of tumor-bearing rabbit serum prepared
by the method of Brugge and Erikson."3 Antibodies in
this serum were able to react with both cellular and vi-
ral pp60src. Three dilutions of extract were used to es-
tablish conditions of antibody excess. Thirty microliters
of extract (150 ,Mg protein) were incubated with 5 MI of
tumor-bearing rabbit serum in microfuge tubes for 1
hour at 4 C. Twenty-five microliters of 50% (vol/vol)
protein A-Sepharose in 20 mM Tris HCl (pH 7.2), 5
mM MgCl2 was added to each tube to precipitate the
immune complexes formed. Immunoprecipitates were
pelleted and washed three times with 50 mM Tris HCl
(pH 7.2), 0.15 M NaCl (400 1.l each wash); once with
2.5 M KCl, 60mM Tris HCl (pH 7.2) (400 Ml); and once
with 40 mM Tris HCl (pH 7.2), 10mM MgCl2 (400 pl).
The reaction mixture containing 50 nM adenosine
triphosphate (ATP) (3.6,Ci [y-32P], New England Nu-
clear; 2900 Ci/mmol), 20mM Tris HCl (pH 7.2), 5 mM
MgCl2, and 5 mM dithiothreitol was added to the
washed immunoprecipitates and incubated at 37 C for
10 minutes. To terminate the reaction, we heated the
samples at 95 C for 1 minute. Free y-32P-ATP was re-
moved by pelleting of the immunoprecipitate and wash-
ing three times in 20 mM Tris HCl (pH 7.2), 5 mM
MgCl2 (400 Ml each wash), followed by electrophoresis
on 8.5% SDS-polyacrylamide gels. The extent of phos-
phorylation of antibody heavy chains was quantitated
by counting gel slices excised from the dried gels for
32P in Aquasol (New England Nuclear, Boston, Mass).
The immune complex protein kinase assay measures the
extent, rather than the rate, of the reaction: the anti-
body and the kinase do not dissociate and maximal
phosphorylation of the antibody is reached within a
few minutes of incubation. 13a Because conditions of
antibody excess are employed in all studies reported
here, the amount of antibody phosphorylation mea-
sures the amount of the enzyme in the immunoprecipi-
tate, rather than its initial velocity. The ATP concen-
tration used in the assay is similar to the apparent Km
for ATP (56 nM) of pp6OC-src from chick embryo
fibroblasts. 4 One unit of activity was defined as the
amount of pp6Oc-src kinase catalyzing the transfer of
1 fmol of phosphate from ATP to the heavy chain of
tumor-bearing rabbit immunoglobulin G (IgG) in 10
minutes at 37 C under the conditions of the assay.
Immune complex kinase assays were also carried out
using a monoclonal antibody to the Rous sarcoma vi-
rus pp6Ov-src protein (Oncor, Inc., Gaithersburg, Md).
This antibody recognizes pp6Oc-src from normal human
cells but does not serve as a substrate for phosphoryla-
tion by pp60src. During the kinase assay, pp6Osrc be-
comes autophosphorylated and can be observed as a
labeled band of about 60,000 Mr by autoradiography
following SDS-polyacrylamide gel electrophoresis.
Ammonium P',P4di(adenosine-5')tetraphosphate
(Ap4A) (Sigma Chemical Co., St. Louis, Mo) was
treated as previously described'5 to hydrolyze any ATP
or adenosine diphosphate (ADP) present. Where indi-
cated, Ap4A was added to the immune complex prior
to the addition of y-32P-ATP. Epidermal growth factor
(KOR Biochemicals, Cambridge, Mass) and insulin
(Sigma) were obtained commercially. Platelet-derived
growth factor was kindly provided by Dr. Jack Pledger
(University of North Carolina).
Phosphoamino Acid Analysis
Following the immune complex protein kinase assay,
the radioactively labeled antibody heavy chain bands
were excised from SDS gels stained with Coomassie
blue, and eluted electrophoretically. Protein was precipi-
tated in the presence of bovine serum albumin (1 mg/ml)
as carrier protein with 15 Vo (wt/vol) trichloroacetic acid.
Precipitates were rinsed with ethanol ether (11, vol/vol)
and air-dried overnight. Proteins were hydrolyzed at 110
C in 6 N HCl for 2 hours under vacuum. Phosphoamino
acids in the samples were analyzed on cellulose thin-
layer sheets by electrophoresis in one dimension, fol-
lowed by ascending chromatography in the second
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* One unit of activity is defined as the amount of pp60c-src catalyzing
the transfer of 1 fmol phosphate from ATP to the heavy chain of tumor-
bearing rabbit IgG in the immune complex under the conditions of the
assay.
t The data are averages of activities determined in extracts of tissues
from five 20-32-week fetuses and three adults.
dimension, as previously described. 16 Phosphoserine,
phosphothreonine, phosphotyrosine (Sigma) were used
as markers and visualized by Ninhydrin staining.
Results
Distribution of pp6Oc-src Kinase Activity in Human
Fetal and Adult Tissues
The expression of pp6Oc-src in human fetal and adult
tissues was determined by measurement of its protein
kinase activity using the immune complex protein ki-
nase assay. pp6Oc-src was quantitatively immunoprecipi-
tated from human tissue extracts with tumor-bearing
rabbit serum under conditions of antibody excess,
and phosphorylation of antibody heavy chains by
pp6Oc-src was carried out in the immunoprecipitates
as described in Materials and Methods. Significant
amounts of pp6Oc-src protein kinase activity was found
in all fetal and adult tissues examined (Table 1). Fetal
brain contained the highest levels of pp6Oc-src kinase
activity; but fetal kidney, spinal cord, and heart also
had substantially high levels. Fetal liver and skeletal
muscle had the lowest levels of activity. Interestingly,
all fetal tissues showed three- to eightfold higher levels
of pp6Oc-src kinase activity than the corresponding
adult tissues. The brain showed the highest levels of
pp60c-src kinase activity among adult tissues. These
results indicate an increase in pp6Oc-src expression in
human neural tissues, if one assumes that pp6Oc-src
from the various tissues examined possesses the same
specific activity.
To investigate whether pp6Oc-src was localized in dis-
crete regions of the brain, we prepared extracts from
dissected regions of an adult human brain and analyzed
for pp6Oc-src kinase. Adult frontal, occipital, and parie-





* One unit of activity is defined as the amount of pp6o0-src catalyzing
the transfer of 1 fmol phosphate from ATP to the heavy chain of tumor-
bearing rabbit IgG in the immune complex under the conditions of the
assay.
t The data are averages from triplicate determinations.
amounts of pp6Oc-src kinase activity, exposed per mil-
ligram of extract protein (Table 2). This suggests that
pp6Oc-src may be uniformly distributed throughout the
brain. Two human glial brain tumors, a malignant as-
trocytoma and an ependymoma, were also analyzed for
pp6Oc-src kinase but were found to exhibit pp6Oc-src ki-
nase activities within normal range.
The protein kinase activity of pp6Oc-src from chick
embryo fibroblasts is known to exhibit specificity for
tyrosine residues in substrate proteins. 12. 6 As confirma-
tion that the kinase activity immunoprecipitated from
human tissues had the expected properties of pp6c-src,
phosphoamino acid analysis was carried out on the
tumor-bearing rabbit antibody phosphorylated in vitro
by pp6Oc-src from human fetal brain (Figure 1). It can
be clearly seen that the only amino acid residue of
the antibody that was phosphorylated by the brain ki-
nase was tyrosine.
The phosphorylation of tumor-bearing rabbit anti-
bodies in immunoprecipitates from human tissues did
not appear due to other known growth-factor-related
cellular tyrosine kinases that might be present in the
immunoprecipitates. Cell membrane receptors for epi-
dermal growth factor (EGF),'7 platelet-derived growth
factor (PDGF),'8 and insulin'9'20 have tyrosine-specific
protein kinase activities that are activated upon bind-
ing of the ligand. Because the tumor-bearing rabbit an-
tiserum might cross-react with these related proteins,
it was essential to determine whether the growth factor
receptor kinases were present in the immunoprecipitates.
pp6Oc-src was immunoprecipitated from fetal brain ex-
tracts with tumor-bearing rabbit antiserum, and assays
were carried out in the usual manner except that 72 nM
EGF, 164 nM PDGF, or 86 nM insulin was added to
the immunoprecipitates prior to the addition of y_32P_
ATP. No augmentation of phosphorylation was ob-
served in the presence of growth factors. In the absence
or presence of growth factors, the protein kinase ac-
tivity was 11 U/mg protein. Thus, the observed phos-
phorylation of tumor-bearing rabbit antibodies can-
not be attributed to these protein kinases. Moreover,
Vol. 119 * No. 1




Figure 1- Phosphoamino acid analysis of 32P-labeled tumor-bearing rab-
bit IgG phosphorylated by pp60c-src from human fetal brain. Immune com-
plex kinase reactions with extract from 32-week fetal brain tissue were run
in triplicate. After electrophoresis on SDS-polyacrylamide gels, the gel
pieces containing the IgG heavy chains were cut, and the triplicate sam-
ples were pooled and eluted electrophoretically. After two-dimensional
phosphoamino acid analysis, the radioactivity was located by autoradiog-
raphy. The origin is at the lower left. Electrophoresis was carried out in
the first dimension toward the anode at the right. Ascending chromatog-
raphy was carried out in the second dimension toward to top. The dotted
circles show the position of Ninhydrin-stained phosphotyrosine (P. TYR.),
phosphothreonine (P.THR.) and phosphoserine (P.SER.).
autoradiograms of the gels did not show phosphoryla-
tion of proteins other than the 53,000 Mr antibody
heavy chains. If growth-factor-stimulated protein
kinases were present, they would become labeled dur-
ing the autophosphorylation reaction and appear in the
higher molecular weight regions of the gel, because all
receptors have subunit molecular weights significantly
greater than 53,000 daltons.17'78 20 Furthermore, the
tumor-bearing rabbit serum used in these experiments
did not immunoprecipitate EGF receptor kinase activity
from a partially purified preparation ofEGF receptor,5
in agreement with other reports that tumor-bearing rab-
bit antibodies fail to immunoprecipitate the EGF recep-
tor, even though they may serve as a phosphoacceptor
substrate for the purified EGF receptor kinase when
assayed in solution.21.22
Immunoprecipitation and Autophosphorylation
of pp6Oc-src With a Monoclonal Antibody
pp60src is also known to carry out autophosphory-
lation at tyrosine residues when incubated with ATP
in the absence of an exogenous phosphoacceptor
substrate.2324 To further document the presence of
pp60c-src in human tissues, we carried out the immune
complex kinase assay with a monoclonal antibody that
recognizes pp60src but does not serve as a phosphoac-
ceptor for pp60src kinase activity. Incubating immune
complexes of pp60c-src and the monoclonal antibody
under the conditions used for the immune complex pro-
tein kinase assay results in the autophosphorylation of
pp60src. Figure 2 shows the results of an experiment
in which pp60c-src was immunoprecipitated with the
monoclonal antibody from representative neural tissues,
human fetal brain and spinal cord, and assayed for au-
tophosphorylation in the immune complex. Electropho-
resis of the proteins on SDS-polyacrylamide gels, fol-
lowed by autoradiography, revealed a phosphorylated
protein of about 60,000 Mr, the expected size of
pp60c-src. pp60v-src, the transforming protein of Rous
sarcoma virus, also showed the expected autophos-
phorylation following immunoprecipitation with the
monoclonal antibody from extracts of chick embryo
fibroblasts infected with Rous sarcoma virus. A labeled
protein of about 52,000 Mr was also observed in im-
munoprecipitates from Rous sarcoma virus-trans-
formed chick embryo fibroblasts. This band probably
represents the 52,000 Mr proteolytic cleavage product
of pp6Osrc that contains the protein kinase domain.25.26
Longer exposures of the autoradiogram similarly re-
vealed small amounts of this product in the human fetal
brain and spinal cord immunoprecipitates. Autophos-
phorylation of a 60,000 Mr band following immuno-
precipitation with the monoclonal antibody provides
strong evidence for the identification of pp6Oc-src in
these tissues. However, we cannot entirely rule out the
presence of the ceHular oncogenes ros,27fgr,28 and yes,29
which are tyrosine kinases whose molecular weights are
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Figure 2-Autophosphorylation of pp6Osrc immunoprecipitated by a
monoclonal antibody. The immune complex kinase assay was carried out
with normal rabbit IgG (Lane 1) or a monoclonal antibody to pp6Oc.src
which does not serve as phosphoacceptor for pp6Oc-,rc kinase activity
(Lanes 2-4). Extracts were prepared from fetal spinal cord (Lanes 1 and
2), fetal brain (Lane 3), and RSV-transformed chick embryo fibroblasts
(Lane 4).
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Figure 3-Differential inhibition of pp6Ovsrc and human pp60c-src by Ap4A.
The phosphorylation of tumor-bearing rabbit IgG by pp6Ov-src from RSV-
transformed chick embryo fibroblasts (0) or pp6Oc-src from 32-week hu-
man fetal brain tissue (C) was measured in immunoprecipitates in the
presence of the indicated concentrations of Ap4A, and the percent inhibi-
tion of activity was calculated. The uninhibited activities of pp6Ov-src and
pp60c-src were 7800 and 1400 cpm of 32p incorporated into IgG heavy
chains under the conditions of the assay, respectively.
Inhibition of pp6Oc-src Kinase Activity by Ap4A
The diadenosine nucleotide can be used as a marker
for pp6Oc-src from normal cells. We demonstrated pre-
viously that the protein kinase activities of pp6Oc-src
and pp60v-src are inhibited by Ap4A,15 but that the pro-
tein kinase activity of pp60c-src is much less sensitive
to inhibition than that of pp60v-src.s.14 The protein ki
nase activity of pp60c-src from human fetal brain was
therefore compared with that of pp60v-src in terms of
its sensitivity to inhibition by Ap4A. pp6Oc-src was im-
munoprecipitated from human fetal brain extracts with
tumor-bearing rabbit serum, and phosphorylation of
antibody heavy chains was carried out in the presence
of various amounts of Ap4A and 90 nM ATP in the
immune complex assay as described.14 The concen-
tration of Ap4A required for 50% inhibition of the
pp60c-src activity from fetal brain was found to be 12.5
MM, whereas a value of 0.5 MM was obtained for
pp60v-src immunoprecipitated from extracts of RSV-
transformed chick embryo fibroblasts in parallel with
the use of the same antiserum. Thus, the observed 25-
fold difference in sensitivity to Ap4A between pp6Oc-src
from human brain and pp60v-src indicates that the ac-
tivity of human pp6Oc-src is similar to that of pp6Oc-src
from chick embryo fibroblasts14 or neural retinal cells.5
Discussion
To investigate the expression of human pp60c-src, we
used the immune complex kinase assay for quantitat-
ing the amount of pp6Oc-src kinase activity in various
tissues obtained from human adults or fetuses of 20-32
weeks' gestation. Significant levels of pp60c-src were
found in all tissues examined, but the highest levels of
expression were found in human fetal brain. Interest-
ingly, all fetal tissues demonstrated a higher level of ac-
tivity than the corresponding adult tissues, implicat-
ing a role for pp60c-src in developmental processes.
pp60c-src in human tissues was demonstrated not only
by the immune complex protein kinase assay, but also
by the tyrosine-specific phosphorylation of tumor-
bearing rabbit IgG, autophosphorylation of a 60,000
Mr band following immunoprecipitation with a mono-
clonal antibody, and sensitivity of the kinase activity
to inhibition by Ap4A.
The structural similarity between retroviral oncogenes
capable of causing transformation and cellular on-
cogenes suggests that the cellular homologs may them-
selves have oncogenic potential. Two cloned cellular on-
cogenes, c-mos and c-ras, when attached to a retroviral
long terminal repeat, a strong promoter for transcrip-
tion, caused rapid cell proliferation of rat cells in cul-
ture, demonstrating that overproduction of these on-
cogenes could induce transformation of normal cell
types.30-33 For other oncogenes such as human cellular
rasH, mutations within the protein coding sequence of
the gene appear to engender transforming potential.
The src gene appears to be in this category as well. The
last 12 amino acids in pp6Ov-src are replaced by 19 com-
pletely new amino acids in pp6c-src, and other single
amino acid substitutions are present elsewhere in the
sequence.34 Hyperexpression of the molecularly cloned
c-src gene from an active promoter in culture rat cells
gave rise to levels of pp60c-src three times greater than
that of pp60v-src in transformed cells, yet with an ap-
parently normal phenotype.35 Further evidence for a
functional difference between pp6Ov-src and pp60c-src is
demonstrated by the differential sensitivity to inhibi-
tion by Ap4A.14 The concentration of Ap4A required
for 50% inhibition of pp6Ov-src kinase activity from
transformed chick embryo fibroblasts is at least 25-fold
less than that required for inhibition of chicken or hu-
man pp60c-src.
A clear role for pp60c-src or a structurally aberrant
homolog in human malignancies has not yet been es-
tablished. Elevation of pp6c-src protein kinase activ-
ity was observed in 5 of 9 spontaneous human sarcomas
and 10 of 21 mammary adenocarcinomas.9 Elevated c-
src-related transcripts were present in leukemic cells of
a patient with chronic myelogenous leukemia and in
circulating tumor cells of a patient with lymphosar-
coma.36 Interpretation of these results is complicated
by the inability in many cases to directly compare the
Vol. 119 * No. 1
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kinase or transcriptional activity from both tumor and
homologous normal tissue from the same patient and
the transcriptional activation of several other cellular
oncogenes within the same leukemic cells. Thus far, no
human tumors or cell lines have been identified con-
taining a c-src gene capable of causing transformation
of animal cells in culture.
The preferential expression of human pp6Oc-src in
brain and its elevated level in the fetus is consistent with
studies of pp6Oc-src expression during chick embryo-
genesis. pp6Oc-src reached maximal levels of expression
during the mid to late organogenetic period of chick
development and was present at highest levels in chick
neural tissues.3 4 Increased levels of pp6Oc-src kinase ac-
tivity have also been documented in brain tissue of fish.2
An elevated level of pp6Oc-src found in brain extract
prepared from a fetus of 18 weeks' gestational age was
previously reported by Jacobs and Rubsamen9 in agree-
ment with the studies presented here. Immunocyto-
chemical localization of pp6Oc-src in the developing
chick neural retina demonstrated that pp6Oc-src was ex-
pressed in developing retinal neurons at the onset of
differentiation.5 Immunoreactive staining was especially
prominent in the ganglion fiber layer and plexiform
layers, which are almost entirely composed of nerve cell
processes. Expression of pp6Oc-src persisted in mature
retinal neurons that were postmitotic and fully differen-
tiated, suggesting that the c-src gene is more important
in neuronal differentiation or function than cell prolifer-
ation. The human cerebral cortex has a full comple-
ment of nerve cells by the middle of gestation, when
we have observed the highest level of fetal tissues for
pp6Oc-src expression." However, many young neurons
are still present within the fiber tract of the intermedi-
ate zone during the last trimester, and a great many in-
terrelated developmental events are still occurring in
which pp60c-src could participate. The presence of
pp6Oc-src in other tissues demonstrates that its func-
tion is not restricted to cells of the neuronal lineage.
pp6Oc-src may modulate developmental events which
are especially prominent in neuronal development, but
common to many cell types, such as the formation of
specific cell-cell contacts that occur during synaptogen-
esis. Moreover, the persistence of pp6Oc-src in adult tis-
sues, albeit at lower levels, indicates that pp6Oc-src is not
solely involved in developmental processes, but may also
participate in adult functions.
Cellular oncogenes homologous to the transforming
genes of other retroviruses may also have a potential
role in developmental processes. Transcripts of the cel-
lular oncogenes c-fos, c-abl, and c-fms are expressed
at highest levels in extraembryonic tissues during mouse
embryogenesis.38 In humans, the level of c-fos gene tran-
scripts is 100-fold greater in human term fetal mem-
branes (chorion and amnion) than in other normal tis-
sues, and the c-fms gene is expressed at high levels
specifically in term placenta.39 Taken together with our
results, these studies suggest that embryologic devel-
opment, and perhaps maintenance of differentiated
function, may depend on the normal function of cel-
lular oncogenes.
References
1. Bishop JM, Varmus H: Functions and origins of retroviral
transforming genes, RNA Tumor Viruses. Edited by
R Weiss, N Teich, H Varmus, J Coffin. Cold Spring Har-
bor, NY, Cold Spring Harbor Laboratory, 1982, pp
999-1108
2. Schartl M, Barnekow A: The expression in eukaryotes
of a tyrosine kinase which is reactive with pp6Ov-src anti-
bodies. Differentiation 1982, 23: 109-114
3. Cotton PC, Brugge JS: Neuronal tissues express high lev-
els of the cellular src gene product pp6c-src. Mol Cell
Biol 1983, 3:1157-1162
4. Levy BT, Sorge LK, Meymandi A, Maness PF: pp6Oc-src
is in chick and human embryonic tissues. Dev Biol (In
press)
5. Sorge LK, Levy BT, Maness PF: pp6Oc-src is developmen-
tally regulated in the neural retina. Cell 1984, 36:249-257
6. Rohrschneider LR, Eisenman RN, Leitch CR: Identifica-
tion of a Rous sarcoma virus transformation-related pro-
tein in normal avian and mammalian cells. Proc Natl
Acad Sci USA 1979, 76:4479-4483
7. Opperman H, Levinson AD, Varmus HE, Levintow L,
Bishop JM: Uninfected vertebrate cells contain a protein
that is closely related to the product of the avian sarcoma
virus transforming gene (src). Proc Natl Acad Sci USA
1979, 76:1804-1808
8. Shealy DJ, Erickson RL: Human cells contain two forms
of pp6fc-src. Nature 1981, 293:666-669
9. Jacobs C, Rubsamen H: Expression of pp6ocsrc protein
kinase in adult and fetal human tissue: High activities
in some sarcomas and mammary carcinomas. Cancer Res
1983, 43:1696-1702
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Pro-
tein measurement with the Folin phenol regent. J Biol
Chem 1951, 193:265-275
11. Maness PF, Engeser H, Greenberg ME, O'Farrell M, Gall
WE, Edelman GM: Characterization of the protein ki-
nase activity of avian sarcoma virus src gene product.
Proc Natl Acad Sci USA 1979, 76:5028-5032
12. Collett MS, Erikson RL: Protein kinase activity associated
with the avian sarcoma virus src gene product. Proc Natl
Acad Sci USA 1978, 75:2021-2024
13. Brugge JS, Erikson RL: Identification of a transforma-
tion specific antigen induced by an avian sarcoma virus.
Nature 1977, 269:346-348
13a. Richert N, Blithe DL, Pastan I: Properties of the src
kinase purified from Rous sarcoma virus rat tumors.
J Biol Chem 1982, 257:7143-7150
14. Levy BT, Sorge LK, Crum CD, Maness PF: Differential
inhibition of cellular and viral pp6Osrc kinase by P,P4-
di(adenosine-5')tetraphosphate. Mol Cell Biol 1983,
3:1718-1723
15. Maness PF, Perry MC, Levy BT: P'Ptdi(adenosine 5'-)te-
traphosphate inhibits phosphorylation of immunoglobu-
lin G by Rous sarcoma virus pp6Osrc. J Biol Chem 1983,
251:4055-4058
16. Hunter T, Sefton B: Transforming gene product of Rous
sarcoma virus phosphorylates tyrosine. Proc Natl Acad
Sci USA 1980, 77:1311-1315
17. Ushiro H, Cohen S: Identification of phosphotyrosine
Vol. 119 * No. 1 pp6Oc src EXPRESSION IN HUMAN TISSUES 157
as a product of epidermal growth factor-activated pro-
tein kinase in A-431 cell membranes. J Biol Chem 1980,
255:8363-8365
18. Ek B, Westermark B, Wasteson A, Heldin A: Stimula-
tion of tyrosine-specific phosphorylation by platelet-
derived growth factor. Nature 1982, 295:419-420
19. Kasuga M, Zick Y, Blithe DC, Crettaz M, Kahn CR: In-
sulin stimulated tyrosine phosphorylation of the insulin
receptor in a cell-free system. Nature 1982, 298:667-669
20. Kasuga M, Karlsson FA, Kahn CR: Insulin stimulates the
phosphorylation of the 95,000-dalton subunit of its own
receptor. Science 1982, 215:185-186
21. Chinkers M, Cohen S: Purified EGF receptor-kinase in-
teracts specifically with antibodies to Rous sarcoma vi-
rus transforming protein. Nature 1981, 290:516-519
22. Kudlow JE, Buss JE, Gill GN: Anti-pp60src antibodies
are substrates for EGF-stimulated protein kinase. Nature
1981, 290:519-521
23. Purchio AF: Evidence that pp6Osrc, the product of the
Rous sarcoma virus src gene, undergoes autophos-
phorylation. J Virol 1982, 41:1-7
24. Sefton BM, Patchinsky T, Berdot C, Hunter T, Elliot T:
Phosphorylation and metabolism of the transforming
protein of Rous sarcoma virus. J Virol 1982, 41:813-820
25. Blithe DL, Richert ND, Pastan IH: Purification of a
tyrosine-specific protein kinase from Rous sarcoma virus-
induced rat tumor. J Biol Chem 1982, 257:7135-7142
26. Levinson AD, Opperman H, Varmus HE, Bishop JM:
The purified product of the transforming gene of avian
sarcoma virus phosphorylates tyrosine. J Biol Chem 1980,
255:11973-11980
27. Feldman RA, Wang LH, Hanafusa H, Balduzzi PC:
Avian sarcoma virus UR2 encodes a transforming pro-
tein which is associated with a unique protein kinase ac-
tivity. J Virol 1982, 42:228-236
28. Naharro G, Robbins KC, Reddy EP: Gene product of
v-fgr onc:hybrid protein containing a portion of actin and
a tyrosin-specific kinase. Science 1984, 223:63-66
29. Yoshida M, Kawai S, Toyoshima K: Uninfected avian cells
contain structurally unrelated progenitors of viral sar-
coma genes. Nature 1980, 287:653-654
30. Oskarsson M, McClements WL, Blair DG, Maizel JV,
Vande Woude GF: Properties of a normal mouse cell
DNA sequence of Moloney sarcoma virus. Science 1980,
207:1222-1224
31. Blair DG, Oskarsson M, Wood TG, McClements L,
Fishinger PF, Vande Woude GF: Activation of the trans-
forming potential of a normal cell sequence: A molecu-
lar model for oncogenesis. Science 1981, 212:941-943
32. Defeo D, Gonda MA, Young HA, Change EH, Lowy DR,
Sednick E, Ellis RW: Analysis of two divergent rat
genomic clones homologous to the transforming genes
of Harvey murine sarcoma virus. Proc Natl Acad Sci USA
1981, 78:3328-3332
33. Chang EH, Furth ME, Scolnick EM, Lowy DR: Tumori-
genic transformation of mammalian cells induced by a
normal human gene homologous to the oncogenes of
Harvey murine sarcoma virus. Nature 1981, 297:479-483
34. Takeya T, Hanafusa H: DNA sequence of the viral and
cellular src gene of chickens: II. Comparison of the src
genes of two strains of avian sarcoma virus and of the
cellular homolog. J Virol 1981, 44:12-18
35. Parker RC, Varmus HE, Bishop JM: Expression of v-src
and chicken c-src in rat cells demonstrates qualitative
differences between pp6Ov-src and pp6Oc-src. Cell 1948,
37:131-139
36. Slamon DJ, deKernion JB, Verma IM, Cline MJ: Expres-
sion of cellular oncogenes in human malignancies. Science
1984, 224:256-262
37. Sidman RL and Rakic D: Development of the human
central nervous system. Histology and histopathology
of the nervous system. Edited by RD Adams, W
Haymaker. Springfield, Ill, Charles C Thomas, 1982,
pp 3-145
38. Mueller R, Slamon DF, Tremblay JM, Cline MJ, Verma
IM: Differential expression of cellular oncogenes during
pre- and post-natal development of the mouse. Nature
1982, 299:640-644
39. Mueller R, Tremblay JM, Adamson ED, Verma IM: Tis-
sue and cell type-specific expression of two human c-onc
genes. Nature 1983, 304:454-456
